BI 730460 / Boehringer Ingelheim - LARVOL DELTA

This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood. (clinicaltrials.gov) - P1 | N=48 | Terminated | Sponsor: Boehringer Ingelheim | Completed ➔ Terminated; The trial was ended after completion of dose group 6 of the SRD part, in accordance with a predefined protocol discontinuation criteria. The planned bioavailability evaluation was not performed due to the sponsor's decision.

Trial termination